XML 22 R8.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Earnings
Accumulated Earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2017     56,501        
Beginning balance at Dec. 31, 2017 $ 1,188,202 $ (1,564) $ 565 $ 686,962 $ (172,407) $ 673,082 $ (1,564)
Increase (Decrease) in Stockholders' Equity              
Net income 65,636         65,636  
Other comprehensive income (loss) (50,964)       (50,964)    
Stock-based compensation 16,792     16,792      
Issuance of common stock for restricted share vesting, net of employee tax withholding (in shares)     160        
Issuance of common stock for restricted share vesting, net of employee tax withholdings $ (3,266)   $ 1 (3,267)      
Repurchases of common stock (in shares) (800)   (814)        
Repurchases of common stock $ (45,080)   $ (8) (45,072)      
Ending balance (in shares) at Dec. 31, 2018     55,847        
Ending balance at Dec. 31, 2018 1,169,756   $ 558 655,415 (223,371) 737,154  
Increase (Decrease) in Stockholders' Equity              
Net income 97,740         97,740  
Other comprehensive income (loss) 13,320       13,320    
Stock-based compensation 17,816     17,816      
Issuance of common stock for restricted share vesting, net of employee tax withholding (in shares)     249        
Issuance of common stock for restricted share vesting, net of employee tax withholdings $ (7,429)   $ 3 (7,432)      
Repurchases of common stock (in shares) (300)   (298)        
Repurchases of common stock $ (21,390)   $ (3) (21,387)      
Ending balance (in shares) at Dec. 31, 2019     55,798        
Ending balance at Dec. 31, 2019 1,269,813   $ 558 644,412 (210,051) 834,894  
Increase (Decrease) in Stockholders' Equity              
Net income 134,837         134,837  
Other comprehensive income (loss) (1,426)       (1,426)    
Stock-based compensation 18,502     18,502      
Issuance of common stock for restricted share vesting, net of employee tax withholding (in shares)     179        
Issuance of common stock for restricted share vesting, net of employee tax withholdings $ (5,331)   $ 2 (5,333)      
Repurchases of common stock (in shares) (1,200)   (1,204)        
Repurchases of common stock $ (74,844)   $ (12) (74,832)      
Ending balance (in shares) at Dec. 31, 2020     54,773        
Ending balance at Dec. 31, 2020 $ 1,341,551   $ 548 $ 582,749 $ (211,477) $ 969,731